dsm-firmenich’s faster-acting vit D gains novel food approval

Clinically backed by more than 15 human studies, ampli-D is a calcifediol (calcidiol) ingredient that helps raise blood vitamin D levels 2.5 times faster and more effectively than conventional vitamin D3โ€‹.

The official EU authorization, which comes three years after EFSA green lighted the ingredient’s safety and bioavailability profileโ€‹, approves ampli-D for a maximum daily dose of 10 ยตg in children over the age of 11 and adults including pregnant and lactating women, and a maximum daily dose of 5 ยตg for children between the ages of 3 and 10. The delay on the official approval was due to the need to confirm conversion factors for different ages.

The firm said the approval marks a major milestone in dsm-firmenichโ€™s ambition to help consumers in the EU unlock the health benefits of the โ€˜sunshine vitaminโ€™ more rapidlyโ€”which include support for immunity, healthy aging, mobility and more. A five-year exclusive use period has been granted for dsm-firmenich to place ampli-D on the market starting May 1.

“With 88% of the global population having sub-optimal vitamin D levels,ย the approval of our game-changing ampli-D ingredient as a novel food in the EU means more people will have access to a solution that can raise levels of this essential vitamin in weeks, rather than months,” said Catherine Mignot, head of regulatory affairs HNC, EMEA at dsm-firmenich. “This landmark approval further demonstrates our role as an end-to-end partner for nutraceutical brands, with our scientific and regulatory expertise paving the way for the commercialization of fast-acting, consumer-centric products that make the world a healthier place.”



Source link


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

>